Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04758338 · ClinicalTrials.gov registry record · NA
Enhancing Cancer Care Of Rural Dwellers
A NA study of Cancer, sponsored by Debra Friedman.
- Active
- Registry status
- NA
- Development phase
- 814
- Enrollment target
- 5
- Study locations
NCT04758338: Active NA study of Cancer, sponsored by Debra Friedman.
NCT04758338 is a NA study of Cancer that is active but no longer recruiting, run by Debra Friedman. The registered enrollment target is 814 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (77% lower). The trial reports 5 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04758338, a NA study of Cancer, is active but no longer recruiting, sponsored by Debra Friedman.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 814 participants
- Enrollment target
- 5
- Study locations
Study Summary
Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive cancer center in these communities
Conditions Studied
Interventions
- OTHER Interview
- OTHER VUMC telehealth services
- OTHER Educational materials
Study Locations (5)
Tennessee
- Baptist Cancer Center- Bartlett - Bartlett
- Ballad Health Systems - Kingsport
- Vanderbilt-Ingram Cancer Center - Nashville
Mississippi
- Baptist Cancer Center- Golden Triangle Columbus - Columbus
- Baptist Cancer Center - North Mississippi - Oxford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 814 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2031-12 |
| Phase | NA |
What the registry record for NCT04758338 still lists
NCT04758338 is an interventional study that assigns participants to a tested intervention. The registered 814 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which Interview is the first listed.
NCT04758338 lists 5 locations in 2 states (Tennessee, Mississippi).
Frequently Asked Questions
What is clinical trial NCT04758338 about?
NCT04758338 is a clinical study titled "Enhancing Cancer Care Of Rural Dwellers". Through a multi-level remote intervention, the Vanderbilt-Ingram Cancer Center (VICC) seeks to improve comprehensive cancer care delivery to patients residing in rural communities with persistent poverty. We plan to do this by using telehealth to broaden the reach of our NCI-designated comprehensive...
What is the current status of trial NCT04758338?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 814 participants. The study started on 2021-10-25. Estimated completion is 2031-12.
What conditions does trial NCT04758338 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT04758338?
The interventions under investigation include: Interview (OTHER), VUMC telehealth services (OTHER), Educational materials (OTHER).
Who is sponsoring clinical trial NCT04758338?
This trial is sponsored by Debra Friedman, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04758338 being conducted?
This trial has 5 study locations across Mississippi, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04758338's enrollment target sits among peer trials
814 92nd of 615 higher than 524 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07218029 · 815 participants · Phase 3
A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI